TECELRA 10000000000 1/1
afamitresgene autoleucel · INJECTION, SUSPENSION · USWM, LLC
Tecelra is a cell therapy injection given intravenously that is used to treat certain types of cancer. It works by modifying your own immune cells to help fight cancer cells in your body.
Key Facts
- Brand Name
- TECELRA
- Generic Name
- afamitresgene autoleucel
- NDC Code (Product)
83205-0001- Manufacturer
- USWM, LLC
- Strength
- 10000000000 1/1
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125789
- Marketing Start
- 08/02/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is TECELRA used for?
Tecelra is a cell therapy injection given intravenously that is used to treat certain types of cancer. It works by modifying your own immune cells to help fight cancer cells in your body.
Is TECELRA a controlled substance?
TECELRA is not classified as a controlled substance by the DEA.
What is the generic name for TECELRA?
The generic name for TECELRA is afamitresgene autoleucel. There are no other listed brand versions of afamitresgene autoleucel.
What is the NDC code for TECELRA 10000000000 1/1?
The NDC (National Drug Code) for TECELRA 10000000000 1/1 is 83205-0001, listed by USWM, LLC.
Other TECELRA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)